News
In essence, decentralization depends on ecosystem-wide changes. “I believe we are at a crossroads in the cell and gene therapy industry,” Åmellem says.
Under this agreement, BCA’s national network of blood centers will provide decentralized manufacturing services for Galapagos’ CAR-T cell therapy product candidates, close to cancer treatment ...
This week’s episode of “The Top Line,” is the final part of a three-part series diving into the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s ...
Lonza’s platform for autologous cell therapy manufacturing, the Cocoon, is a functionally closed, automated system that is currently being used to support clinical trials in Europe and North America, ...
To keep pace with expected T-cell therapy approvals—up to 20 each year by 2025—manufacturers must gain the ability to produce millions of doses.
Innovative cell and gene therapies (CGTs) have significantly disrupted the treatment landscape for several genetic diseases. In recent years, the number of CGT approvals has been on an upward ...
This week’s episode of “The Top Line” is the second part of a three-part series exploring the latest advancements in cell and gene therapy manufacturing. In this episode, Fierce Pharma’s ...
Cell Therapy Manufacturing Operation To Expand In Maryland Kite will build a 70,000-square-foot raw materials warehouse next to its existing facility in Frederick County, adding 100 jobs. 01/11/2023 ...
ANN ARBOR, Mich., June 24, 2025 /PRNewswire/ -- Akadeum Life Sciences, the world leader in advanced cell separation technology, proudly announces a groundbreaking workflow that leverages its ...
Excellos Inc., a cell therapy contract and development manufacturing organization member of Blood Centers of America, today announced that it has been selected to manufacture Galapagos’ CAR-T ...
Excellos Selected as Decentralized Manufacturing Unit to Support Galapagos’ CAR-T Cell Therapy Clinical Study Close to Cancer Treatment Centers in the San Diego Area Oct. 01, 2024 6:00 AM ET ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results